2 terminated, 1 recruiting. 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 2, Recruiting 1 |
| Phase 1 | 2 | Terminated 2 |
Follow Ovary Neoplasm: new trials by email Literature Review of Ovary Neoplasm trials Research Report on Ovary Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy Tart Cherry Juice - Breast Cancer, Breast Cancer Stage I | Phase 2 | Recruiting | University of California, Davis | 86 | 2024-08-15 | 2026-03-04 |
| Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors Neoantigen specific TCR-T cell drug product, Aldesleukin (IL-2) - Gynecologic Cancer, Colorectal Cancer | Phase 1 / Phase 2 | Terminated | Alaunos Therapeutics | 8 | 2022-04-04 | 2025-11-10 |
| A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRĪ±) ELU001 - Ovarian Cancer, Ovarian Neoplasms | Phase 1 / Phase 2 | Terminated | Elucida Oncology | 79 | 2021-09-13 | 2024-08-07 |
Ovarian Neoplasms (3) · Endometrial Neoplasms (2) · Adenocarcinoma of Lung (1) · Breast Neoplasms (1) · Carcinoma (1) · Carcinoma, Endometrioid (1) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Ovarian Epithelial (1) · Cholangiocarcinoma (1) · Colorectal Neoplasms (1) · Fallopian Tube Neoplasms (1) · Krukenberg Tumor (1) · Ovarian Diseases (1) · Pancreatic Neoplasms (1) · Recurrence (1)
Adnexal Diseases (3) · Endocrine Gland Neoplasms (3) · Endocrine System Diseases (3) · Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Genital Diseases (3) · Genital Diseases, Female (3) · Genital Neoplasms, Female (3) · Gonadal Disorders (3) · Neoplasms (3) · Neoplasms by Site (3) · Urogenital Diseases (3) · Urogenital Neoplasms (3) · Adenocarcinoma (2) · Neoplasms by Histologic Type (2)
Interleukin-2 (1) · aldesleukin (1)
Alaunos Therapeutics (1) · Elucida Oncology (1) · University of California, Davis (1)
United States (3)
Eve Rodler, MD (1) · Scott Kopetz, MD, PhD (1)